Global CRISPR and CRISPR-Associated (Cas) Genes Supply, Demand and Key Producers, 2026-2032
The global CRISPR and CRISPR-Associated (Cas) Genes market size is expected to reach $ 20810 million by 2032, rising at a market growth of 31.2% CAGR during the forecast period (2026-2032).
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of 'spacer DNA' from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
This report studies the global CRISPR and CRISPR-Associated (Cas) Genes demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CRISPR and CRISPR-Associated (Cas) Genes, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of CRISPR and CRISPR-Associated (Cas) Genes that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CRISPR and CRISPR-Associated (Cas) Genes total market, 2021-2032, (USD Million)
Global CRISPR and CRISPR-Associated (Cas) Genes total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: CRISPR and CRISPR-Associated (Cas) Genes total market, key domestic companies, and share, (USD Million)
Global CRISPR and CRISPR-Associated (Cas) Genes revenue by player, revenue and market share 2021-2026, (USD Million)
Global CRISPR and CRISPR-Associated (Cas) Genes total market by Type, CAGR, 2021-2032, (USD Million)
Global CRISPR and CRISPR-Associated (Cas) Genes total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global CRISPR and CRISPR-Associated (Cas) Genes market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world CRISPR and CRISPR-Associated (Cas) Genes market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global CRISPR and CRISPR-Associated (Cas) Genes Market, By Region:
1. How big is the global CRISPR and CRISPR-Associated (Cas) Genes market?
2. What is the demand of the global CRISPR and CRISPR-Associated (Cas) Genes market?
3. What is the year over year growth of the global CRISPR and CRISPR-Associated (Cas) Genes market?
4. What is the total value of the global CRISPR and CRISPR-Associated (Cas) Genes market?
5. Who are the Major Players in the global CRISPR and CRISPR-Associated (Cas) Genes market?
6. What are the growth factors driving the market demand?
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of 'spacer DNA' from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
This report studies the global CRISPR and CRISPR-Associated (Cas) Genes demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CRISPR and CRISPR-Associated (Cas) Genes, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of CRISPR and CRISPR-Associated (Cas) Genes that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CRISPR and CRISPR-Associated (Cas) Genes total market, 2021-2032, (USD Million)
Global CRISPR and CRISPR-Associated (Cas) Genes total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: CRISPR and CRISPR-Associated (Cas) Genes total market, key domestic companies, and share, (USD Million)
Global CRISPR and CRISPR-Associated (Cas) Genes revenue by player, revenue and market share 2021-2026, (USD Million)
Global CRISPR and CRISPR-Associated (Cas) Genes total market by Type, CAGR, 2021-2032, (USD Million)
Global CRISPR and CRISPR-Associated (Cas) Genes total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global CRISPR and CRISPR-Associated (Cas) Genes market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world CRISPR and CRISPR-Associated (Cas) Genes market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global CRISPR and CRISPR-Associated (Cas) Genes Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Genome Editing
- Genetic engineering
- gRNA Database/Gene Librar
- CRISPR Plasmid
- Human Stem Cells
- Genetically Modified Organisms/Crops
- Cell Line Engineering
- Biotechnology Companies
- Pharmaceutical Companies
- Academic Institutes
- Research and Development Institutes
- Thermo Fisher Scientific
- Editas Medicine
- Caribou Biosciences
- CRISPR therapeutics
- Intellia therapeutics, Inc.
- Cellectis
- Horizon Discovery Plc
- Sigma Aldrich
- Precision Biosciences
- Genscript
- Sangamo Biosciences Inc.
- Lonza Group Limited
- Integrated DNA Technologies
- New England Biolabs
- Origene Technologies
1. How big is the global CRISPR and CRISPR-Associated (Cas) Genes market?
2. What is the demand of the global CRISPR and CRISPR-Associated (Cas) Genes market?
3. What is the year over year growth of the global CRISPR and CRISPR-Associated (Cas) Genes market?
4. What is the total value of the global CRISPR and CRISPR-Associated (Cas) Genes market?
5. Who are the Major Players in the global CRISPR and CRISPR-Associated (Cas) Genes market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 CRISPR and CRISPR-Associated (Cas) Genes Introduction
1.2 World CRISPR and CRISPR-Associated (Cas) Genes Market Size & Forecast (2021 & 2025 & 2032)
1.3 World CRISPR and CRISPR-Associated (Cas) Genes Total Market by Region (by Headquarter Location)
1.3.1 World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.3.3 China Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.3.4 Europe Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.3.5 Japan Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.3.6 South Korea Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.3.7 ASEAN Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.3.8 India Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.2 World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Region
2.2.1 World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Region (2021-2026)
2.2.2 World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Forecast by Region (2027-2032)
2.3 United States CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.4 China CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.5 Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.6 Japan CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.7 South Korea CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.8 ASEAN CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.9 India CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
3 WORLD CRISPR AND CRISPR-ASSOCIATED (CAS) GENES COMPANIES COMPETITIVE ANALYSIS
3.1 World CRISPR and CRISPR-Associated (Cas) Genes Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CRISPR and CRISPR-Associated (Cas) Genes in 2025
3.2.3 Global Concentration Ratios (CR8) for CRISPR and CRISPR-Associated (Cas) Genes in 2025
3.3 CRISPR and CRISPR-Associated (Cas) Genes Company Evaluation Quadrant
3.4 CRISPR and CRISPR-Associated (Cas) Genes Market: Overall Company Footprint Analysis
3.4.1 CRISPR and CRISPR-Associated (Cas) Genes Market: Region Footprint
3.4.2 CRISPR and CRISPR-Associated (Cas) Genes Market: Company Product Type Footprint
3.4.3 CRISPR and CRISPR-Associated (Cas) Genes Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Comparison
4.2.1 United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based CRISPR and CRISPR-Associated (Cas) Genes Companies and Market Share, 2021-2026
4.3.1 United States Based CRISPR and CRISPR-Associated (Cas) Genes Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue, (2021-2026)
4.4 China Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue and Market Share, 2021-2026
4.4.1 China Based CRISPR and CRISPR-Associated (Cas) Genes Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue, (2021-2026)
4.5 Rest of World Based CRISPR and CRISPR-Associated (Cas) Genes Companies and Market Share, 2021-2026
4.5.1 Rest of World Based CRISPR and CRISPR-Associated (Cas) Genes Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Genome Editing
5.2.2 Genetic engineering
5.2.3 gRNA Database/Gene Librar
5.2.4 CRISPR Plasmid
5.2.5 Human Stem Cells
5.2.6 Genetically Modified Organisms/Crops
5.2.7 Cell Line Engineering
5.3 Market Segment by Type
5.3.1 World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2021-2026)
5.3.2 World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2027-2032)
5.3.3 World CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Biotechnology Companies
6.2.2 Pharmaceutical Companies
6.2.3 Academic Institutes
6.2.4 Research and Development Institutes
6.3 Market Segment by Application
6.3.1 World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2021-2026)
6.3.2 World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2027-2032)
6.3.3 World CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Details
7.1.2 Thermo Fisher Scientific Major Business
7.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.1.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Thermo Fisher Scientific Recent Developments/Updates
7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.2 Editas Medicine
7.2.1 Editas Medicine Details
7.2.2 Editas Medicine Major Business
7.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.2.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Editas Medicine Recent Developments/Updates
7.2.6 Editas Medicine Competitive Strengths & Weaknesses
7.3 Caribou Biosciences
7.3.1 Caribou Biosciences Details
7.3.2 Caribou Biosciences Major Business
7.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.3.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Caribou Biosciences Recent Developments/Updates
7.3.6 Caribou Biosciences Competitive Strengths & Weaknesses
7.4 CRISPR therapeutics
7.4.1 CRISPR therapeutics Details
7.4.2 CRISPR therapeutics Major Business
7.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.4.4 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 CRISPR therapeutics Recent Developments/Updates
7.4.6 CRISPR therapeutics Competitive Strengths & Weaknesses
7.5 Intellia therapeutics, Inc.
7.5.1 Intellia therapeutics, Inc. Details
7.5.2 Intellia therapeutics, Inc. Major Business
7.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.5.4 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Intellia therapeutics, Inc. Recent Developments/Updates
7.5.6 Intellia therapeutics, Inc. Competitive Strengths & Weaknesses
7.6 Cellectis
7.6.1 Cellectis Details
7.6.2 Cellectis Major Business
7.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.6.4 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Cellectis Recent Developments/Updates
7.6.6 Cellectis Competitive Strengths & Weaknesses
7.7 Horizon Discovery Plc
7.7.1 Horizon Discovery Plc Details
7.7.2 Horizon Discovery Plc Major Business
7.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.7.4 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Horizon Discovery Plc Recent Developments/Updates
7.7.6 Horizon Discovery Plc Competitive Strengths & Weaknesses
7.8 Sigma Aldrich
7.8.1 Sigma Aldrich Details
7.8.2 Sigma Aldrich Major Business
7.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.8.4 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Sigma Aldrich Recent Developments/Updates
7.8.6 Sigma Aldrich Competitive Strengths & Weaknesses
7.9 Precision Biosciences
7.9.1 Precision Biosciences Details
7.9.2 Precision Biosciences Major Business
7.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.9.4 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Precision Biosciences Recent Developments/Updates
7.9.6 Precision Biosciences Competitive Strengths & Weaknesses
7.10 Genscript
7.10.1 Genscript Details
7.10.2 Genscript Major Business
7.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.10.4 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Genscript Recent Developments/Updates
7.10.6 Genscript Competitive Strengths & Weaknesses
7.11 Sangamo Biosciences Inc.
7.11.1 Sangamo Biosciences Inc. Details
7.11.2 Sangamo Biosciences Inc. Major Business
7.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.11.4 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Sangamo Biosciences Inc. Recent Developments/Updates
7.11.6 Sangamo Biosciences Inc. Competitive Strengths & Weaknesses
7.12 Lonza Group Limited
7.12.1 Lonza Group Limited Details
7.12.2 Lonza Group Limited Major Business
7.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.12.4 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Lonza Group Limited Recent Developments/Updates
7.12.6 Lonza Group Limited Competitive Strengths & Weaknesses
7.13 Integrated DNA Technologies
7.13.1 Integrated DNA Technologies Details
7.13.2 Integrated DNA Technologies Major Business
7.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.13.4 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Integrated DNA Technologies Recent Developments/Updates
7.13.6 Integrated DNA Technologies Competitive Strengths & Weaknesses
7.14 New England Biolabs
7.14.1 New England Biolabs Details
7.14.2 New England Biolabs Major Business
7.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.14.4 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 New England Biolabs Recent Developments/Updates
7.14.6 New England Biolabs Competitive Strengths & Weaknesses
7.15 Origene Technologies
7.15.1 Origene Technologies Details
7.15.2 Origene Technologies Major Business
7.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.15.4 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 Origene Technologies Recent Developments/Updates
7.15.6 Origene Technologies Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Chain
8.2 CRISPR and CRISPR-Associated (Cas) Genes Upstream Analysis
8.3 CRISPR and CRISPR-Associated (Cas) Genes Midstream Analysis
8.4 CRISPR and CRISPR-Associated (Cas) Genes Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 CRISPR and CRISPR-Associated (Cas) Genes Introduction
1.2 World CRISPR and CRISPR-Associated (Cas) Genes Market Size & Forecast (2021 & 2025 & 2032)
1.3 World CRISPR and CRISPR-Associated (Cas) Genes Total Market by Region (by Headquarter Location)
1.3.1 World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.3.3 China Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.3.4 Europe Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.3.5 Japan Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.3.6 South Korea Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.3.7 ASEAN Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.3.8 India Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.2 World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Region
2.2.1 World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Region (2021-2026)
2.2.2 World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Forecast by Region (2027-2032)
2.3 United States CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.4 China CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.5 Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.6 Japan CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.7 South Korea CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.8 ASEAN CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
2.9 India CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032)
3 WORLD CRISPR AND CRISPR-ASSOCIATED (CAS) GENES COMPANIES COMPETITIVE ANALYSIS
3.1 World CRISPR and CRISPR-Associated (Cas) Genes Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CRISPR and CRISPR-Associated (Cas) Genes in 2025
3.2.3 Global Concentration Ratios (CR8) for CRISPR and CRISPR-Associated (Cas) Genes in 2025
3.3 CRISPR and CRISPR-Associated (Cas) Genes Company Evaluation Quadrant
3.4 CRISPR and CRISPR-Associated (Cas) Genes Market: Overall Company Footprint Analysis
3.4.1 CRISPR and CRISPR-Associated (Cas) Genes Market: Region Footprint
3.4.2 CRISPR and CRISPR-Associated (Cas) Genes Market: Company Product Type Footprint
3.4.3 CRISPR and CRISPR-Associated (Cas) Genes Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Comparison
4.2.1 United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based CRISPR and CRISPR-Associated (Cas) Genes Companies and Market Share, 2021-2026
4.3.1 United States Based CRISPR and CRISPR-Associated (Cas) Genes Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue, (2021-2026)
4.4 China Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue and Market Share, 2021-2026
4.4.1 China Based CRISPR and CRISPR-Associated (Cas) Genes Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue, (2021-2026)
4.5 Rest of World Based CRISPR and CRISPR-Associated (Cas) Genes Companies and Market Share, 2021-2026
4.5.1 Rest of World Based CRISPR and CRISPR-Associated (Cas) Genes Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Genome Editing
5.2.2 Genetic engineering
5.2.3 gRNA Database/Gene Librar
5.2.4 CRISPR Plasmid
5.2.5 Human Stem Cells
5.2.6 Genetically Modified Organisms/Crops
5.2.7 Cell Line Engineering
5.3 Market Segment by Type
5.3.1 World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2021-2026)
5.3.2 World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2027-2032)
5.3.3 World CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CRISPR and CRISPR-Associated (Cas) Genes Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Biotechnology Companies
6.2.2 Pharmaceutical Companies
6.2.3 Academic Institutes
6.2.4 Research and Development Institutes
6.3 Market Segment by Application
6.3.1 World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2021-2026)
6.3.2 World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2027-2032)
6.3.3 World CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Details
7.1.2 Thermo Fisher Scientific Major Business
7.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.1.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Thermo Fisher Scientific Recent Developments/Updates
7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.2 Editas Medicine
7.2.1 Editas Medicine Details
7.2.2 Editas Medicine Major Business
7.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.2.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Editas Medicine Recent Developments/Updates
7.2.6 Editas Medicine Competitive Strengths & Weaknesses
7.3 Caribou Biosciences
7.3.1 Caribou Biosciences Details
7.3.2 Caribou Biosciences Major Business
7.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.3.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Caribou Biosciences Recent Developments/Updates
7.3.6 Caribou Biosciences Competitive Strengths & Weaknesses
7.4 CRISPR therapeutics
7.4.1 CRISPR therapeutics Details
7.4.2 CRISPR therapeutics Major Business
7.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.4.4 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 CRISPR therapeutics Recent Developments/Updates
7.4.6 CRISPR therapeutics Competitive Strengths & Weaknesses
7.5 Intellia therapeutics, Inc.
7.5.1 Intellia therapeutics, Inc. Details
7.5.2 Intellia therapeutics, Inc. Major Business
7.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.5.4 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Intellia therapeutics, Inc. Recent Developments/Updates
7.5.6 Intellia therapeutics, Inc. Competitive Strengths & Weaknesses
7.6 Cellectis
7.6.1 Cellectis Details
7.6.2 Cellectis Major Business
7.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.6.4 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Cellectis Recent Developments/Updates
7.6.6 Cellectis Competitive Strengths & Weaknesses
7.7 Horizon Discovery Plc
7.7.1 Horizon Discovery Plc Details
7.7.2 Horizon Discovery Plc Major Business
7.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.7.4 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Horizon Discovery Plc Recent Developments/Updates
7.7.6 Horizon Discovery Plc Competitive Strengths & Weaknesses
7.8 Sigma Aldrich
7.8.1 Sigma Aldrich Details
7.8.2 Sigma Aldrich Major Business
7.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.8.4 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Sigma Aldrich Recent Developments/Updates
7.8.6 Sigma Aldrich Competitive Strengths & Weaknesses
7.9 Precision Biosciences
7.9.1 Precision Biosciences Details
7.9.2 Precision Biosciences Major Business
7.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.9.4 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Precision Biosciences Recent Developments/Updates
7.9.6 Precision Biosciences Competitive Strengths & Weaknesses
7.10 Genscript
7.10.1 Genscript Details
7.10.2 Genscript Major Business
7.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.10.4 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Genscript Recent Developments/Updates
7.10.6 Genscript Competitive Strengths & Weaknesses
7.11 Sangamo Biosciences Inc.
7.11.1 Sangamo Biosciences Inc. Details
7.11.2 Sangamo Biosciences Inc. Major Business
7.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.11.4 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Sangamo Biosciences Inc. Recent Developments/Updates
7.11.6 Sangamo Biosciences Inc. Competitive Strengths & Weaknesses
7.12 Lonza Group Limited
7.12.1 Lonza Group Limited Details
7.12.2 Lonza Group Limited Major Business
7.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.12.4 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Lonza Group Limited Recent Developments/Updates
7.12.6 Lonza Group Limited Competitive Strengths & Weaknesses
7.13 Integrated DNA Technologies
7.13.1 Integrated DNA Technologies Details
7.13.2 Integrated DNA Technologies Major Business
7.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.13.4 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Integrated DNA Technologies Recent Developments/Updates
7.13.6 Integrated DNA Technologies Competitive Strengths & Weaknesses
7.14 New England Biolabs
7.14.1 New England Biolabs Details
7.14.2 New England Biolabs Major Business
7.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.14.4 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 New England Biolabs Recent Developments/Updates
7.14.6 New England Biolabs Competitive Strengths & Weaknesses
7.15 Origene Technologies
7.15.1 Origene Technologies Details
7.15.2 Origene Technologies Major Business
7.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Services
7.15.4 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 Origene Technologies Recent Developments/Updates
7.15.6 Origene Technologies Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Chain
8.2 CRISPR and CRISPR-Associated (Cas) Genes Upstream Analysis
8.3 CRISPR and CRISPR-Associated (Cas) Genes Midstream Analysis
8.4 CRISPR and CRISPR-Associated (Cas) Genes Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World CRISPR and CRISPR-Associated (Cas) Genes Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key CRISPR and CRISPR-Associated (Cas) Genes Players in 2025
Table 12. World CRISPR and CRISPR-Associated (Cas) Genes Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Company Evaluation Quadrant
Table 14. Head Office of Key CRISPR and CRISPR-Associated (Cas) Genes Players
Table 15. CRISPR and CRISPR-Associated (Cas) Genes Market: Company Product Type Footprint
Table 16. CRISPR and CRISPR-Associated (Cas) Genes Market: Company Product Application Footprint
Table 17. CRISPR and CRISPR-Associated (Cas) Genes Mergers & Acquisitions Activity
Table 18. United States VS China CRISPR and CRISPR-Associated (Cas) Genes Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based CRISPR and CRISPR-Associated (Cas) Genes Companies, Headquarters (States, Country)
Table 21. United States Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share (2021-2026)
Table 23. China Based CRISPR and CRISPR-Associated (Cas) Genes Companies, Headquarters (Province, Country)
Table 24. China Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share (2021-2026)
Table 26. Rest of World Based CRISPR and CRISPR-Associated (Cas) Genes Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share (2021-2026)
Table 29. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World CRISPR and CRISPR-Associated (Cas) Genes Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2027-2032) & (USD Million)
Table 32. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2021-2026) & (USD Million)
Table 34. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2027-2032) & (USD Million)
Table 35. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 38. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Thermo Fisher Scientific Recent Developments/Updates
Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 41. Editas Medicine Basic Information, Manufacturing Base and Competitors
Table 42. Editas Medicine Major Business
Table 43. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 44. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Editas Medicine Recent Developments/Updates
Table 46. Editas Medicine Competitive Strengths & Weaknesses
Table 47. Caribou Biosciences Basic Information, Manufacturing Base and Competitors
Table 48. Caribou Biosciences Major Business
Table 49. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 50. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Caribou Biosciences Recent Developments/Updates
Table 52. Caribou Biosciences Competitive Strengths & Weaknesses
Table 53. CRISPR therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. CRISPR therapeutics Major Business
Table 55. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 56. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. CRISPR therapeutics Recent Developments/Updates
Table 58. CRISPR therapeutics Competitive Strengths & Weaknesses
Table 59. Intellia therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Intellia therapeutics, Inc. Major Business
Table 61. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 62. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Intellia therapeutics, Inc. Recent Developments/Updates
Table 64. Intellia therapeutics, Inc. Competitive Strengths & Weaknesses
Table 65. Cellectis Basic Information, Manufacturing Base and Competitors
Table 66. Cellectis Major Business
Table 67. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 68. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Cellectis Recent Developments/Updates
Table 70. Cellectis Competitive Strengths & Weaknesses
Table 71. Horizon Discovery Plc Basic Information, Manufacturing Base and Competitors
Table 72. Horizon Discovery Plc Major Business
Table 73. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 74. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Horizon Discovery Plc Recent Developments/Updates
Table 76. Horizon Discovery Plc Competitive Strengths & Weaknesses
Table 77. Sigma Aldrich Basic Information, Manufacturing Base and Competitors
Table 78. Sigma Aldrich Major Business
Table 79. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 80. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Sigma Aldrich Recent Developments/Updates
Table 82. Sigma Aldrich Competitive Strengths & Weaknesses
Table 83. Precision Biosciences Basic Information, Manufacturing Base and Competitors
Table 84. Precision Biosciences Major Business
Table 85. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 86. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Precision Biosciences Recent Developments/Updates
Table 88. Precision Biosciences Competitive Strengths & Weaknesses
Table 89. Genscript Basic Information, Manufacturing Base and Competitors
Table 90. Genscript Major Business
Table 91. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 92. Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Genscript Recent Developments/Updates
Table 94. Genscript Competitive Strengths & Weaknesses
Table 95. Sangamo Biosciences Inc. Basic Information, Manufacturing Base and Competitors
Table 96. Sangamo Biosciences Inc. Major Business
Table 97. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 98. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Sangamo Biosciences Inc. Recent Developments/Updates
Table 100. Sangamo Biosciences Inc. Competitive Strengths & Weaknesses
Table 101. Lonza Group Limited Basic Information, Manufacturing Base and Competitors
Table 102. Lonza Group Limited Major Business
Table 103. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 104. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Lonza Group Limited Recent Developments/Updates
Table 106. Lonza Group Limited Competitive Strengths & Weaknesses
Table 107. Integrated DNA Technologies Basic Information, Manufacturing Base and Competitors
Table 108. Integrated DNA Technologies Major Business
Table 109. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 110. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Integrated DNA Technologies Recent Developments/Updates
Table 112. Integrated DNA Technologies Competitive Strengths & Weaknesses
Table 113. New England Biolabs Basic Information, Manufacturing Base and Competitors
Table 114. New England Biolabs Major Business
Table 115. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 116. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. New England Biolabs Recent Developments/Updates
Table 118. New England Biolabs Competitive Strengths & Weaknesses
Table 119. Origene Technologies Basic Information, Manufacturing Base and Competitors
Table 120. Origene Technologies Major Business
Table 121. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 122. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Origene Technologies Recent Developments/Updates
Table 124. Origene Technologies Competitive Strengths & Weaknesses
Table 125. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes Upstream (Raw Materials)
Table 126. Global CRISPR and CRISPR-Associated (Cas) Genes Typical Customers
Table 1. World CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World CRISPR and CRISPR-Associated (Cas) Genes Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key CRISPR and CRISPR-Associated (Cas) Genes Players in 2025
Table 12. World CRISPR and CRISPR-Associated (Cas) Genes Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Company Evaluation Quadrant
Table 14. Head Office of Key CRISPR and CRISPR-Associated (Cas) Genes Players
Table 15. CRISPR and CRISPR-Associated (Cas) Genes Market: Company Product Type Footprint
Table 16. CRISPR and CRISPR-Associated (Cas) Genes Market: Company Product Application Footprint
Table 17. CRISPR and CRISPR-Associated (Cas) Genes Mergers & Acquisitions Activity
Table 18. United States VS China CRISPR and CRISPR-Associated (Cas) Genes Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based CRISPR and CRISPR-Associated (Cas) Genes Companies, Headquarters (States, Country)
Table 21. United States Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share (2021-2026)
Table 23. China Based CRISPR and CRISPR-Associated (Cas) Genes Companies, Headquarters (Province, Country)
Table 24. China Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share (2021-2026)
Table 26. Rest of World Based CRISPR and CRISPR-Associated (Cas) Genes Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share (2021-2026)
Table 29. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World CRISPR and CRISPR-Associated (Cas) Genes Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2027-2032) & (USD Million)
Table 32. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2021-2026) & (USD Million)
Table 34. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2027-2032) & (USD Million)
Table 35. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 38. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Thermo Fisher Scientific Recent Developments/Updates
Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 41. Editas Medicine Basic Information, Manufacturing Base and Competitors
Table 42. Editas Medicine Major Business
Table 43. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 44. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Editas Medicine Recent Developments/Updates
Table 46. Editas Medicine Competitive Strengths & Weaknesses
Table 47. Caribou Biosciences Basic Information, Manufacturing Base and Competitors
Table 48. Caribou Biosciences Major Business
Table 49. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 50. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Caribou Biosciences Recent Developments/Updates
Table 52. Caribou Biosciences Competitive Strengths & Weaknesses
Table 53. CRISPR therapeutics Basic Information, Manufacturing Base and Competitors
Table 54. CRISPR therapeutics Major Business
Table 55. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 56. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. CRISPR therapeutics Recent Developments/Updates
Table 58. CRISPR therapeutics Competitive Strengths & Weaknesses
Table 59. Intellia therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Intellia therapeutics, Inc. Major Business
Table 61. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 62. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Intellia therapeutics, Inc. Recent Developments/Updates
Table 64. Intellia therapeutics, Inc. Competitive Strengths & Weaknesses
Table 65. Cellectis Basic Information, Manufacturing Base and Competitors
Table 66. Cellectis Major Business
Table 67. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 68. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Cellectis Recent Developments/Updates
Table 70. Cellectis Competitive Strengths & Weaknesses
Table 71. Horizon Discovery Plc Basic Information, Manufacturing Base and Competitors
Table 72. Horizon Discovery Plc Major Business
Table 73. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 74. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Horizon Discovery Plc Recent Developments/Updates
Table 76. Horizon Discovery Plc Competitive Strengths & Weaknesses
Table 77. Sigma Aldrich Basic Information, Manufacturing Base and Competitors
Table 78. Sigma Aldrich Major Business
Table 79. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 80. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Sigma Aldrich Recent Developments/Updates
Table 82. Sigma Aldrich Competitive Strengths & Weaknesses
Table 83. Precision Biosciences Basic Information, Manufacturing Base and Competitors
Table 84. Precision Biosciences Major Business
Table 85. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 86. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Precision Biosciences Recent Developments/Updates
Table 88. Precision Biosciences Competitive Strengths & Weaknesses
Table 89. Genscript Basic Information, Manufacturing Base and Competitors
Table 90. Genscript Major Business
Table 91. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 92. Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Genscript Recent Developments/Updates
Table 94. Genscript Competitive Strengths & Weaknesses
Table 95. Sangamo Biosciences Inc. Basic Information, Manufacturing Base and Competitors
Table 96. Sangamo Biosciences Inc. Major Business
Table 97. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 98. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Sangamo Biosciences Inc. Recent Developments/Updates
Table 100. Sangamo Biosciences Inc. Competitive Strengths & Weaknesses
Table 101. Lonza Group Limited Basic Information, Manufacturing Base and Competitors
Table 102. Lonza Group Limited Major Business
Table 103. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 104. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Lonza Group Limited Recent Developments/Updates
Table 106. Lonza Group Limited Competitive Strengths & Weaknesses
Table 107. Integrated DNA Technologies Basic Information, Manufacturing Base and Competitors
Table 108. Integrated DNA Technologies Major Business
Table 109. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 110. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Integrated DNA Technologies Recent Developments/Updates
Table 112. Integrated DNA Technologies Competitive Strengths & Weaknesses
Table 113. New England Biolabs Basic Information, Manufacturing Base and Competitors
Table 114. New England Biolabs Major Business
Table 115. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 116. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. New England Biolabs Recent Developments/Updates
Table 118. New England Biolabs Competitive Strengths & Weaknesses
Table 119. Origene Technologies Basic Information, Manufacturing Base and Competitors
Table 120. Origene Technologies Major Business
Table 121. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product and Services
Table 122. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Origene Technologies Recent Developments/Updates
Table 124. Origene Technologies Competitive Strengths & Weaknesses
Table 125. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes Upstream (Raw Materials)
Table 126. Global CRISPR and CRISPR-Associated (Cas) Genes Typical Customers
LIST OF FIGURES
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Picture
Figure 2. World CRISPR and CRISPR-Associated (Cas) Genes Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World CRISPR and CRISPR-Associated (Cas) Genes Total Revenue (2021-2032) & (USD Million)
Figure 4. World CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 13. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 16. World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Region (2021-2032)
Figure 17. United States CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 18. China CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 23. India CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of CRISPR and CRISPR-Associated (Cas) Genes by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for CRISPR and CRISPR-Associated (Cas) Genes Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for CRISPR and CRISPR-Associated (Cas) Genes Markets in 2025
Figure 27. United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type in 2025
Figure 31. Genome Editing
Figure 32. Genetic engineering
Figure 33. gRNA Database/Gene Librar
Figure 34. CRISPR Plasmid
Figure 35. Human Stem Cells
Figure 36. Genetically Modified Organisms/Crops
Figure 37. Cell Line Engineering
Figure 38. Cell Line Engineering
Figure 39. World CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2021-2032)
Figure 40. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application in 2025
Figure 42. Biotechnology Companies
Figure 43. Pharmaceutical Companies
Figure 44. Academic Institutes
Figure 45. Research and Development Institutes
Figure 46. World CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2021-2032)
Figure 47. CRISPR and CRISPR-Associated (Cas) Genes Industrial Chain
Figure 48. Methodology
Figure 49. Research Process and Data Source
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Picture
Figure 2. World CRISPR and CRISPR-Associated (Cas) Genes Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World CRISPR and CRISPR-Associated (Cas) Genes Total Revenue (2021-2032) & (USD Million)
Figure 4. World CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company CRISPR and CRISPR-Associated (Cas) Genes Revenue (2021-2032) & (USD Million)
Figure 13. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 16. World CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share by Region (2021-2032)
Figure 17. United States CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 18. China CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 23. India CRISPR and CRISPR-Associated (Cas) Genes Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of CRISPR and CRISPR-Associated (Cas) Genes by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for CRISPR and CRISPR-Associated (Cas) Genes Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for CRISPR and CRISPR-Associated (Cas) Genes Markets in 2025
Figure 27. United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: CRISPR and CRISPR-Associated (Cas) Genes Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type in 2025
Figure 31. Genome Editing
Figure 32. Genetic engineering
Figure 33. gRNA Database/Gene Librar
Figure 34. CRISPR Plasmid
Figure 35. Human Stem Cells
Figure 36. Genetically Modified Organisms/Crops
Figure 37. Cell Line Engineering
Figure 38. Cell Line Engineering
Figure 39. World CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2021-2032)
Figure 40. World CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application in 2025
Figure 42. Biotechnology Companies
Figure 43. Pharmaceutical Companies
Figure 44. Academic Institutes
Figure 45. Research and Development Institutes
Figure 46. World CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2021-2032)
Figure 47. CRISPR and CRISPR-Associated (Cas) Genes Industrial Chain
Figure 48. Methodology
Figure 49. Research Process and Data Source
